With the evolution of COVID-19, Theradiag is committed to providing the medical community with the necessary products to aid in the COVID-19 response.
Theradiag IMMUNO-TROL Quality Controls are unassayed non-kit controls. This means that the controls do not have values or reference ranges assigned by the manufacturer.
Please find below a summary of the recently published British guidelines on the management of inflammatory bowel disease in adults.
Theradiag are the market leaders in Therapeutic Drug Monitoring (TDM) with assays validated and supported by the pharmaceutical industry.
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease. Painchart C, Brabant S et al; Dig Dis Sci. 2019 Oct 10.
Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases.